PIK3CA and neoplasm: More recently, the analysis of KRAS, BRAF and PIK3CA in tumour invasion fronts, lymph nodes and distant metastases revealed a discordance between primary tumours and lymph node metastases of 31, 4 and 13%, respectively (Baldus et al, 2010).